The Median Effective Dose of Remimazolam for Duodenoscopy Insertion During ERCP With Alfentanil 10µg/kg
Clinical trial NCT04969068 · UNKNOWN
Trial details
- NCT number
- NCT04969068
- Sponsor
- Tianjin Nankai Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-23
- Primary completion
- 2021-12-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.